CAS 132201-33-3

(2R,3S)-N-benzoil-3-fenilisoserina

Fórmula: C₁₆H₁₅NO₄

InChI: InChI=1S/C16H15NO4/c18-14(16(20)21)13(11-7-3-1-4-8-11)17-15(19)12-9-5-2-6-10-12/h1-10,13-14,18H,(H,17,19)(H,20,21)/t13-,14+/m0/s1

Chave InChI: InChIKey=HYJVYOWKYPNSTK-UONOGXRCSA-N

SMILES: [C@@H](NC(=O)C1=CC=CC=C1)([C@H](C(O)=O)O)C2=CC=CC=C2

Sinónimos:

• (2R,3S)-2-hydroxy-3-phenyl-3-[(phenylcarbonyl)amino]propanoic acid
• (2R,3S)-3-(Benzoylamino)-2-hydroxy-3-phenylpropanoic acid
• (2R,3S)-3-(Benzoylamino)-2-hydroxy-3-phenylpropionic acid
• (2R,3S)-N-Benzoyl-3-phenylisoserine
• (αR,βS)-β-(Benzoylamino)-α-hydroxybenzenepropanoic acid
• Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, (αR,βS)-
• Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, [R-(R*,S*)]-
• N-benzoyl-(3S,2R)-3-phenylisoserine
• benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, (alphaR,betaS)-
• N-Benzoyl-(2R,3S)-3-phenylisoserine

N-Benzoyl-(2R,3S)-3-phenylisoserine

CAS: 132201-33-3

N-Benzoyl-(2R,3S)-3-phenylisoserine

Fórmula: C₁₆H₁₅NO₄

Pureza: ≥98%, 10 mM in DMSO

Peso molecular: 285.29

Ref: 54-BUP11873

Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, (αR,βS)-

CAS: 132201-33-3

Fórmula: C₁₆H₁₅NO₄

Pureza: 97%

Cor e Forma: Solid

Peso molecular: 285.2946

Ref: IN-DA0010DS

N-Benzoyl-(2R,3S)-3-phenylisoserine

CAS: 132201-33-3

Peso molecular: 285.29

Ref: 7W-GM1874

N-Benzoyl-(2R,3S)-3-phenylisoserine

CAS: 132201-33-3

Fórmula: C₁₆H₁₅NO₄

Pureza: 95%~99%

Peso molecular: 285.299

Ref: BP-BP4345

(2R,3S)-3-(Benzoylamino)-2-hydroxy-3-phenylpropanoic Acid ((2R,3S)-N-Benzoyl-3-phenylisoserine)

Produto Controlado

CAS: 132201-33-3

Fórmula: C₁₆H₁₅NO₄

Cor e Forma: Neat

Peso molecular: 285.29

Ref: 86-MM1489.06

Paclitaxel Side Chain Impurity 1

CAS: 132201-33-3

Fórmula: C₁₆H₁₅NO₄

Peso molecular: 285.30

Ref: 4Z-P-2832

N-Benzoyl-(2R,3S)-3-phenylisoserine

CAS: 132201-33-3

N-Benzoyl-(2R,3S)-3-phenylisoserine (taxol side chain) is an intermediate in the preparation of potent anticancer drug Paclitaxel, used to study the location of

Fórmula: C₁₆H₁₅NO₄

Pureza: 99.10%

Cor e Forma: White Solid

Peso molecular: 285.29

Ref: TM-T7054

N-Benzoyl-(2R,3S)-3-phenylisoserine

CAS: 132201-33-3

N-Benzoyl-(2R,3S)-3-Phenylisoserine

Fórmula: C₁₆H₁₅NO₄

Pureza: 97%

Peso molecular: 285.29

Ref: IN-DG41247

(2R,3S)-N-Benzoyl-3-phenyl Isoserine

Produto Controlado

CAS: 132201-33-3

Impurity Paclitaxel Side Chain Impurity 1
Applications (2R,3S)-N-Benzoyl-3-phenylisoserine is an intermediate in the preparation of potent anticancer drug Paclitaxel (P132500) used to study the location of the binding sites. (2R,3S)-N-Benzoyl-3-phenylisoserine shows cytotoxic, antiviral and immunomodulatory activity. Paclitaxel Side Chain Impurity 1.
References Paal, K. et al.: Bioorg. Med. Chem., 15, 1323 (2007); Krawczyk, E. et al.: J. Pharm. Pharmacol., 57, 791 (2005);

Fórmula: C₁₆H₁₅NO₄

Cor e Forma: Neat

Peso molecular: 285.29

Ref: TR-B208550

N-Benzoyl-(2R,3S)-3-phenylisoserine

CAS: 132201-33-3

Ref: BE-RMCP002023

(2R,3S)-3-Benzamido-2-hydroxy-3-phenylpropanoic acid

CAS: 132201-33-3

Fórmula: C₁₆H₁₅NO₄

Pureza: 98%

Peso molecular: 285.299

Ref: 10-F212819

Paclitaxel Impurity 52

CAS: 132201-33-3

Fórmula: C₁₆H₁₅NO₄

Peso molecular: 285.30

Ref: ST-EA-CP-P36012

N-Benzoyl-(2R,3S)-3-amino-2-hydroxy-3-phenyl-propionicacid

CAS: 132201-33-3

N-Benzoyl-(2R,3S)-3-amino-2-hydroxy-3-phenylpropionic acid (BAPA) is a substance that is used in the manufacture of various drugs. It is also a potent anticancer drug that can be used for the treatment of cancer. BAPA has been shown to be an effective chemotherapeutic agent against many types of cancer cells. This drug is synthesized through an asymmetric synthesis process and has been shown to have potent cytotoxic effects against cancer cells with low levels of glutathione peroxide reductase. BAPA also inhibits the growth of bacteria by hydrolyzing or oxidizing proteins or by binding to DNA and RNA.

Fórmula: C₁₆H₁₅NO₄

Pureza: Min. 95%

Peso molecular: 285.29 g/mol

Ref: 3D-FB151111